Saw the news that regulators signed off on a stronger option for the branded semaglutide shot, genuinely not that shocking given the timing. Curious how that plays into the patent situation, my guess is it effectively resets the clock on these higher amounts. Makes me wonder whether tirzepatide's sitting similarly far under its real ceiling too. Haven't come across anything solid yet on the higher tirzepatide doses supposedly in trials. Some speculation floats around 20 or 25mg, though who knows, could end up being considerably higher than that. Guess it's time to consider bumping my own dose.